US · CARL
CARLSMED, INC.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Carlsbad, CA 92008
- Website
- carlsmed.com
Price · as of 2025-12-31
$9.48
Market cap 387.46M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $35.99 | +279.64% |
| Intrinsic Value(DCF) | $4,875.78 | +51,332.28% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $0.00 | $0.00 | |||
| 2025 | $13.37 | $35.99 | $23,240.93 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates CARLSMED, INC.'s (CARL) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $35.99
- Current price
- $9.48
- AI upside
- +279.64%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$4,875.78
+51,332.28% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| CARL | CARLSMED, INC. | $9.48 | 387.46M | +280% | +51,332% | — | — | -6.29 | 1.92 | 3.76 | -3.43 | -15.22 | 1.92 | 75.31% | -60.53% | -59.82% | -214.02% | 70.22% | -33.22% | 0.18 | -21.38 | 8.87 | 8.48 | 2.40 | 4133.00% | 8594.00% | 1549.00% | -15.58% | -2.03 | 68.02% | 0.00% | 0.00% | 23.89% | -3.20 | -3.30 | 1.94 | 3.22 |
About CARLSMED, INC.
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.
- CEO
- Michael John Cordonnier
- Employees
- 100
- Beta
- -0.24
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($4,875.78 ÷ $9.48) − 1 = +51,332.28% (DCF, example).